表紙
市場調查報告書

末梢血管設備的全球市場 - 至2024年的預測:血管成形術用氣球,支架,血管造影術用導管,血管內超音波 (IVUS) 導管,粥樣斑塊切除設備,血栓切除設備,栓塞保護裝置,IVC過濾器,導管導引線

Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters(Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration(Embolic Protection), IVC Filters, Guidewires)-Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 233144
出版日期 內容資訊 英文 191 Pages
訂單完成後即時交付
價格
Back to Top
末梢血管設備的全球市場 - 至2024年的預測:血管成形術用氣球,支架,血管造影術用導管,血管內超音波 (IVUS) 導管,粥樣斑塊切除設備,血栓切除設備,栓塞保護裝置,IVC過濾器,導管導引線 Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters(Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration(Embolic Protection), IVC Filters, Guidewires)-Global Forecast to 2024
出版日期: 2019年02月21日內容資訊: 英文 191 Pages
簡介

末梢血管設備市場預計將從2019年的103億美元,擴大到2024年144億的規模。市場在2019年∼2024年間預測將以年複合成長率 (CAGR) 6.8%的速度成長。

本報告提供全球末梢血管設備市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 末梢血管設備市場概要
  • 北美 - 血管成形術用支架市場
  • 末梢血管設備市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題

第6章 血管成形術用氣球市場:各類型

  • 簡介
  • 舊式/標準球囊
  • 削球/球囊導管
  • 藥物釋放型球囊

第7章 血管成形術用支架市場:各類型

  • 簡介
  • 藥劑溶出性血管支架
  • 傳統金屬支架

第8章 導管市場:各類型

  • 簡介
  • 血管造影術用導管
  • 引導管
  • 血管內超音波 (IVUS) / 光學同調斷層掃描 (OCT) 導管

第9章 血管內動脈瘤修復 (EVAR) 血管支架市場:各類型

  • 簡介
  • 腹部主動脈血管瘤 (AAA)
  • 胸部主動脈瘤 (TAA)

第10章 下腔靜脈 (IVC) 過濾器市場:各類型

  • 簡介
  • 可回收型過濾器
  • 永久型過濾器

第11章 斑塊修飾設備市場:各類型

  • 簡介
  • 粥樣斑塊切除設備
  • 血栓切除設備

第12章 血流改變設備市場:各類型

  • 簡介
  • 栓塞保護裝置
  • 慢性完全阻塞設備

第13章 其他末梢血管設備市場:各類型

  • 簡介
  • 導管導引線
  • 血管閉合設備
  • 導管鞘
  • 球囊擴張設備

第14章 末梢血管設備市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第15章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭模式
  • 競爭領導製圖

第16章 企業簡介

  • MEDTRONIC
  • BOSTON SCIENTIFIC CORPORATION
  • ABBOTT LABORATORIES
  • BECTON, DICKINSON AND COMPANY
  • Terumo Corporation
  • CORDIS (CARDINAL HEALTH, INC.的子公司)
  • B. BRAUN MELSUNGEN AG
  • IVASCULAR
  • BIOSENSORS INTERNATIONAL GROUP LTD.
  • BIOTRONIK
  • PENUMBRA, INC.

第17章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 1254

"Peripheral vascular devices market to register a CAGR of 6.8% from 2019 to 2024"

The peripheral vascular devices market is projected to reach USD 14.4 billion by 2024 from USD 10.3 billion in 2019, at a CAGR of 6.8% during the forecast period. The rapid growth in the geriatric population and the associated increase in the prevalence of peripheral vascular diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries are driving the growth of the peripheral vascular devices.

"Atherectomy devices accounted for the larger share of the plaque modification devices market in 2018"

On the basis of type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices. In 2018, the atherectomy devices segment accounted for the larger market share mainly due to the increasing incidence of atherosclerosis as a result of the rising global prevalence of obesity.

"Embolic protection devices accounted for the largest share of the peripheral vascular devices market in 2018"

On the basis of type, the hemodynamic flow alteration devices market is segmented into embolic protection devices and chronic total occlusion devices. In 2018, the embolic protection devices segment accounted for the larger share of the hemodynamic flow alteration devices market. This can be attributed to the advantages of EPDs over CTO devices, such as the ability to capture embolic debris without interrupting continuous blood flow.

"North America dominates the peripheral vascular devices market"

North America, which includes the US and Canada, accounted for the largest share of the peripheral vascular devices market in 2018. The large share of this market segment can be attributed to the rising incidence of peripheral vascular diseases (PVDs), growing geriatric population, and the strong presence of industry players in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1: 20% , Tier 2: 45%, and Tier 3: 35%
  • By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
  • By Region: North America: 35%, Europe: 24%, Asia: 25%, and the RoW: 16%

The major players operating in this market are: Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).

Research Coverage:

This report studies the peripheral vascular devices market based on product and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total peripheral vascular devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the peripheral vascular devices offered by the top 10 players in the market. The report analyzes the peripheral vascular devices market by product and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various peripheral vascular devices across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the peripheral vascular devices market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the peripheral vascular devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. REGIONAL COVERAGE
    • 1.2.3. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW
  • 4.2. NORTH AMERICA: ANGIOPLASTY STENTS MARKET (2018)
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE PERIPHERAL VASCULAR DEVICES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases
      • 5.2.1.2. Product approvals
      • 5.2.1.3. Increasing prevalence of diabetes
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Product failures and recalls
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Availability of alternative treatments

6. ANGIOPLASTY BALLOONS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. OLD/NORMAL BALLOONS
    • 6.2.1. OLD/NORMAL BALLOONS WILL CONTINUE TO DOMINATE THE ANGIOPLASTY BALLOONS MARKET IN 2024
  • 6.3. CUTTING AND SCORING BALLOONS
    • 6.3.1. CUTTING BALLOONS ARE USED TO TREAT ATHEROSCLEROSIS
  • 6.4. DRUG-ELUTING BALLOONS
    • 6.4.1. DRUG-ELUTING BALLOONS TO WITNESS THE HIGHEST GROWTH IN THE ANGIOPLASTY BALLOONS MARKET DURING THE FORECAST PERIOD

7. ANGIOPLASTY STENTS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. DRUG-ELUTING STENTS
    • 7.2.1. DRUG-ELUTING STENTS TO WITNESS HIGHER ADOPTION PRIMARILY DUE TO THE REDUCED RESTENOSIS RATE ASSOCIATED WITH THESE PRODUCTS
  • 7.3. BARE-METAL STENTS
    • 7.3.1. INCREASING USE OF DRUG-ELUTING STENTS TO RESTRAIN MARKET GROWTH
    • 7.3.2. BARE-METAL STENTS, BY DELIVERY PLATFORM
      • 7.3.2.1. Balloon-expandable stents
      • 7.3.2.2. Self-expandable stents

8. CATHETERS MARKET, BY TYPE

  • 8.1. INTRODUCTION
  • 8.2. ANGIOGRAPHY CATHETERS
    • 8.2.1. ANGIOGRAPHY CATHETERS TO DOMINATE THE CATHETERS MARKET DURING THE FORECAST PERIOD
  • 8.3. GUIDING CATHETERS
    • 8.3.1. GUIDING CATHETERS TO ACCOUNT FOR THE SECOND-LARGEST SHARE OF THE CATHETERS MARKET DURING THE FORECAST PERIOD
  • 8.4. IVUS/OCT CATHETERS
    • 8.4.1. IVUS/OCT CATHETERS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

9. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE

  • 9.1. INTRODUCTION
  • 9.2. ABDOMINAL AORTIC ANEURYSM STENT GRAFTS
    • 9.2.1. ABDOMINAL AORTIC ANEURYSM STENT GRAFTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 9.3. THORACIC AORTIC ANEURYSM STENT GRAFTS
    • 9.3.1. INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO DRIVE MARKET GROWTH IN THE COMING YEARS

10. INFERIOR VENA CAVA FILTERS MARKET, BY TYPE

  • 10.1. INTRODUCTION
  • 10.2. RETRIEVABLE FILTERS
    • 10.2.1. RETRIEVABLE FILTERS SEGMENT TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • 10.3. PERMANENT FILTERS
    • 10.3.1. RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER THEIR SALES DURING THE FORECAST PERIOD

11. PLAQUE MODIFICATION DEVICES MARKET, BY TYPE

  • 11.1. INTRODUCTION
  • 11.2. ATHERECTOMY DEVICES
    • 11.2.1. INCREASING INCIDENCE OF ATHEROSCLEROSIS AS A RESULT OF THE RISING GLOBAL PREVALENCE OF OBESITY-A KEY MARKET DRIVER
  • 11.3. THROMBECTOMY DEVICES
    • 11.3.1. GROWING DVT INCIDENCE TO DRIVE THE ADOPTION OF THROMBECTOMY DEVICES

12. HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE

  • 12.1. INTRODUCTION
  • 12.2. EMBOLIC PROTECTION DEVICES
    • 12.2.1. INCREASING INVESTMENTS IN NEW TECHNOLOGY DEVELOPMENT AND THE GROWING NUMBER OF REGULATORY APPROVALS FOR THESE DEVICES TO DRIVE MARKET GROWTH
  • 12.3. CHRONIC TOTAL OCCLUSION (CTO) DEVICES
    • 12.3.1. INCREASING INVESTMENTS IN THE DEVELOPMENT OF CTO DEVICES TO DRIVE MARKET GROWTH

13. OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE

  • 13.1. INTRODUCTION
  • 13.2. GUIDEWIRES
  • 13.3. VASCULAR CLOSURE DEVICES
  • 13.4. INTRODUCER SHEATHS
  • 13.5. BALLOON INFLATION DEVICES

14. PERIPHERAL VASCULAR DEVICES MARKET, BY REGION

  • 14.1. INTRODUCTION
  • 14.2. NORTH AMERICA
    • 14.2.1. US
      • 14.2.1.1. Favorable reimbursement scenario ensures device adoption in the US
    • 14.2.2. CANADA
      • 14.2.2.1. Rising prevalence of target diseases will drive market growth
  • 14.3. EUROPE
    • 14.3.1. GERMANY
      • 14.3.1.1. Increase in geriatric and obese populations will contribute to device demand
    • 14.3.2. FRANCE
      • 14.3.2.1. Incidence of PE and DVT will increase, corresponding to growth in France's geriatric population
    • 14.3.3. UK
      • 14.3.3.1. Increasing incidence of peripheral vascular diseases to support market growth in the UK
    • 14.3.4. SPAIN
      • 14.3.4.1. Rising geriatric population to increase the demand for peripheral vascular devices in Spain
    • 14.3.5. ITALY
      • 14.3.5.1. Increasing health expenditure and rising diabetes prevalence are the major factors driving market growth in Italy
    • 14.3.6. REST OF EUROPE
  • 14.4. ASIA PACIFIC
    • 14.4.1. JAPAN
      • 14.4.1.1. Presence of a large geriatric population - A major factor supporting market growth in Japan
    • 14.4.2. CHINA
      • 14.4.2.1. Growing target patient population in China to drive market growth
    • 14.4.3. INDIA
      • 14.4.3.1. Increasing prevalence of diabetes to drive the adoption of peripheral vascular devices
    • 14.4.4. REST OF ASIA PACIFIC
  • 14.5. REST OF THE WORLD
    • 14.5.1. LATIN AMERICA
      • 14.5.1.1. Growing geriatric population and the subsequent increase in the prevalence of peripheral artery diseases to drive market growth
    • 14.5.2. MIDDLE EAST & AFRICA
      • 14.5.2.1. Increasing prevalence of diabetes to drive market growth

15. COMPETITIVE LANDSCAPE

  • 15.1. OVERVIEW
  • 15.2. MARKET SHARE ANALYSIS, 2017
  • 15.3. COMPETITIVE SCENARIO
    • 15.3.1. PRODUCT LAUNCHES AND APPROVALS, 2015-2018
    • 15.3.2. ACQUISITIONS, 2015-2018
    • 15.3.3. AGREEMENTS, 2015-2018
    • 15.3.4. EXPANSIONS, 2015-2018
  • 15.4. COMPETITIVE LEADERSHIP MAPPING (2017)
    • 15.4.1. VENDOR INCLUSION CRITERIA
    • 15.4.2. VISIONARY LEADERS
    • 15.4.3. INNOVATORS
    • 15.4.4. DYNAMIC DIFFERENTIATORS
    • 15.4.5. EMERGING COMPANIES
  • 15.5. COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017)
    • 15.5.1. PROGRESSIVE COMPANIES
    • 15.5.2. STARTING BLOCKS
    • 15.5.3. RESPONSIVE COMPANIES
    • 15.5.4. DYNAMIC COMPANIES

16. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 16.1. MEDTRONIC
  • 16.2. BOSTON SCIENTIFIC CORPORATION
  • 16.3. ABBOTT LABORATORIES
  • 16.4. BECTON, DICKINSON AND COMPANY
  • 16.5. TERUMO CORPORATION
  • 16.6. CORDIS (A SUBSIDIARY OF CARDINAL HEALTH, INC.)
  • 16.7. B. BRAUN MELSUNGEN AG
  • 16.8. IVASCULAR
  • 16.9. BIOSENSORS INTERNATIONAL GROUP LTD.
  • 16.10. BIOTRONIK
  • 16.11. PENUMBRA, INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

17. APPENDIX

  • 17.1. INSIGHTS OF INDUSTRY EXPERTS
  • 17.2. DISCUSSION GUIDE
  • 17.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.4. AVAILABLE CUSTOMIZATIONS
  • 17.5. RELATED REPORTS
  • 17.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GERIATRIC POPULATION, BY REGION, 2015 VS. 2030
  • TABLE 2: PRODUCT APPROVALS IN THE PERIPHERAL VASCULAR DEVICES MARKET, 2015-2018
  • TABLE 3: DIABETES POPULATION, BY REGION, 2000 VS. 2030
  • TABLE 4: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 5: ANGIOPLASTY BALLOONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: CUTTING AND SCORING BALLOONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: DRUG-ELUTING BALLOONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: ANGIOPLASTY STENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: ANGIOPLASTY STENTS MARKET, BY REGION, 2017-2024 (THOUSAND UNITS)
  • TABLE 12: DRUG-ELUTING STENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: BARE-METAL STENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: BARE-METAL STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 15: BALLOON-EXPANDABLE STENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: SELF-EXPANDABLE STENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 18: CATHETERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: GUIDING CATHETERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: IVUS/OCT CATHETERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 23: EVAR STENT GRAFTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 27: INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 31: PLAQUE MODIFICATION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: ATHERECTOMY DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: THROMBECTOMY DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 35: EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: CHRONIC OCCLUSION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 38: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 39: GUIDEWIRES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: GUIDEWIRES MARKET, BY REGION, 2015-2024 (THOUSAND UNITS)
  • TABLE 41: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2015-2024 (THOUSAND UNITS)
  • TABLE 43: INTRODUCER SHEATHS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 44: INTRODUCER SHEATHS MARKET, BY REGION, 2015-2024 (THOUSAND UNITS)
  • TABLE 45: BALLOON INFLATION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 46: BALLOON INFLATION DEVICES MARKET, BY REGION, 2017-2024 (THOUSAND UNITS)
  • TABLE 47: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 48: NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 49: NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 50: NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 51: NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 53: NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 54: NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 56: NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 57: US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 58: US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: US: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: US: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61: US: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 62: US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 63: US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 64: US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 65: CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66: CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 67: CANADA: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 68: CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: CANADA: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 70: CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 71: CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 72: CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 74: EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 75: EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 76: EUROPE: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 77: EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 78: EUROPE: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 80: EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 81: EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 82: GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 83: GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: GERMANY: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86: GERMANY: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 87: GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 88: GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 89: GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91: FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92: FRANCE: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 93: FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 94: FRANCE: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95: FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 99: UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 100: UK: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101: UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 102: UK: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105: UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 106: SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 107: SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 108: SPAIN: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: SPAIN: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 111: SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 112: SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 113: SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 114: ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 116: ITALY: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 117: ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 118: ITALY: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 119: ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 120: ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121: ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 122: ROE: HEALTH EXPENDITURE, BY COUNTRY, 2007 VS. 2015 (% OF GDP)
  • TABLE 123: ROE: PERCENTAGE OF GERIATRIC POPULATION TO THE TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 (MILLION)
  • TABLE 124: ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 125: ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 126: ROE: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127: ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 128: ROE: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129: ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 130: ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 131: ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 132: ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 133: ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 134: ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 135: ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 136: ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 137: ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 138: ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 139: ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 140: ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 141: JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 142: JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 143: JAPAN: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 144: JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 145: JAPAN: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 146: JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 147: JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 148: JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 149: CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 150: CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 151: CHINA: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 152: CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 153: CHINA: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 154: CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 155: CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 156: CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 157: INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 158: INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 159: INDIA: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 160: INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 161: INDIA: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 162: INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 163: INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 164: INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 165: REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 166: REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 167: REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 168: REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 169: REST OF ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 170: REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 171: REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 172: REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 173: ROW: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 174: ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 175: ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 176: ROW: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 177: ROW: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 178: ROW: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 179: ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 180: ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 181: ROW: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 182: LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 183: LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 184: LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 185: LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 186: LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 187: LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 188: LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 189: LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 190: MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 191: MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 192: MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 193: MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 194: MIDDLE EAST & AFRICA: IVC FILTERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 195: MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 196: MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 197: MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: PERIPHERAL VASCULAR DEVICES MARKET
  • FIGURE 2: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: PERIPHERAL VASCULAR DEVICES MARKET: BOTTOM-UP APPROACH
  • FIGURE 6: PERIPHERAL VASCULAR DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: ANGIOPLASTY STENTS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: CATHETERS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 12: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 13: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 14: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 15: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 16: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 17: INCREASING PREVALENCE OF PERIPHERAL VASCULAR DISEASES IS EXPECTED TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 18: DRUG-ELUTING STENTS DOMINATED THE NORTH AMERICAN ANGIOPLASTY STENTS MARKET IN 2018
  • FIGURE 19: COUNTRIES IN ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 20: PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 21: PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2019 VS 2024
  • FIGURE 22: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 23: ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 24: KEY DEVELOPMENTS IN THE PERIPHERAL VASCULAR DEVICES MARKET FROM 2015 TO 2019
  • FIGURE 25: SHARE OF COMPANIES IN THE PERIPHERAL VASCULAR DEVICES MARKET, 2017
  • FIGURE 26: MNM DIVE-VENDOR COMPARISON MATRIX: PERIPHERAL VASCULAR DEVICES MARKET
  • FIGURE 27: MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: PERIPHERAL VASCULAR DEVICES MARKET
  • FIGURE 28: MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 29: BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 30: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 31: BD: COMPANY SNAPSHOT
  • FIGURE 32: TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 33: CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
  • FIGURE 34: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • FIGURE 35: PENUMBRA, INC.: COMPANY SNAPSHOT
Back to Top